Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Non-malignant Disease
•
General Radiation Oncology
What dose/fractionation do you recommend for a recurrent Malignant Fibroid Histiocytoma of the Lower Lip that is re-resected with positive margin?
Would you answer change if this was unresectable disease?
Related Questions
How do you counsel cancer patients when they ask if they should avoid sugar?
Is it safe to administer Lu 177 therapies in patients with epidural disease in the spinal canal?
Is there a time interval after which you would not offer adjuvant radiotherapy for a malignant, grade 3 meningioma?
When do you consider elective pelvic nodal irradiation for unfavorable intermediate risk prostate cancer?
How would you manage radiation cystitis in a vulvar cancer patient still receiving EBRT with known history of cystocele and who is otherwise hemodynamically stable?
What are your preferred strategies to manage mild to moderate rectal ulceration causing tenesmus and discomfort after chemoradiation for rectal adenocarcinoma?
Would you offer radiation therapy for a 59 year old female patient with orbital sarcoidosis and no other site of disease who can no longer tolerate systemic therapy?
Do you routinely offer spine SBRT for vertebral metastases regardless of overall patient disease burden or response?
How do you time PET/CT surveillance and COVID boosters?
What vertebral body dose constraint do you use in SBRT to limit compression fracture?